Circulating biomarkers in pulmonary arterial hypertension: State-of-the-art review and future directions
(2024) In JHLT Open 6.- Abstract
- Pulmonary arterial hypertension is a complex and heterogeneous condition, associated with a considerable diagnostic delay, diminished exercise capacity, and poor outcomes. In pulmonary arterial hypertension, biomarker research has become a subject of intense inquiry, and novel circulating biomarkers acknowledged in a multitude of mechanistic pathways are emerging. Beyond the widely used natriuretic peptides, novel biomarkers may provide deeper pathophysiological understanding, support clinical decision-making, and prompt the incorporation of precision medicine by enabling a more precise individual phenotyping. In this state-of-the-art review, the recent advances in circulating biomarkers in pulmonary arterial hypertension from a clinical... (More)
- Pulmonary arterial hypertension is a complex and heterogeneous condition, associated with a considerable diagnostic delay, diminished exercise capacity, and poor outcomes. In pulmonary arterial hypertension, biomarker research has become a subject of intense inquiry, and novel circulating biomarkers acknowledged in a multitude of mechanistic pathways are emerging. Beyond the widely used natriuretic peptides, novel biomarkers may provide deeper pathophysiological understanding, support clinical decision-making, and prompt the incorporation of precision medicine by enabling a more precise individual phenotyping. In this state-of-the-art review, the recent advances in circulating biomarkers in pulmonary arterial hypertension from a clinical perspective are discussed, with particular emphasis on the current state of knowledge, gaps in evidence, and future perspectives. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/f391e616-6dd7-4410-a596-2e6ac672d559
- author
- Ahmed, Salaheldin
LU
; Ahmed, Abdulla LU
and Rådegran, Göran LU
- organization
- publishing date
- 2024-11-01
- type
- Contribution to journal
- publication status
- published
- subject
- in
- JHLT Open
- volume
- 6
- article number
- 100152
- publisher
- Elsevier
- external identifiers
-
- pmid:40145036
- ISSN
- 2950-1334
- DOI
- 10.1016/j.jhlto.2024.100152
- language
- English
- LU publication?
- yes
- id
- f391e616-6dd7-4410-a596-2e6ac672d559
- date added to LUP
- 2025-03-26 14:06:48
- date last changed
- 2025-06-26 03:00:17
@article{f391e616-6dd7-4410-a596-2e6ac672d559, abstract = {{Pulmonary arterial hypertension is a complex and heterogeneous condition, associated with a considerable diagnostic delay, diminished exercise capacity, and poor outcomes. In pulmonary arterial hypertension, biomarker research has become a subject of intense inquiry, and novel circulating biomarkers acknowledged in a multitude of mechanistic pathways are emerging. Beyond the widely used natriuretic peptides, novel biomarkers may provide deeper pathophysiological understanding, support clinical decision-making, and prompt the incorporation of precision medicine by enabling a more precise individual phenotyping. In this state-of-the-art review, the recent advances in circulating biomarkers in pulmonary arterial hypertension from a clinical perspective are discussed, with particular emphasis on the current state of knowledge, gaps in evidence, and future perspectives.}}, author = {{Ahmed, Salaheldin and Ahmed, Abdulla and Rådegran, Göran}}, issn = {{2950-1334}}, language = {{eng}}, month = {{11}}, publisher = {{Elsevier}}, series = {{JHLT Open}}, title = {{Circulating biomarkers in pulmonary arterial hypertension: State-of-the-art review and future directions}}, url = {{http://dx.doi.org/10.1016/j.jhlto.2024.100152}}, doi = {{10.1016/j.jhlto.2024.100152}}, volume = {{6}}, year = {{2024}}, }